Cuál es el precio por Hancock Jaffe Laboratories (HJLI)

Precio por Hancock Jaffe Laboratories (HJLI) es de$10.38

Cuál es la capitalización de mercado por Hancock Jaffe Laboratories (HJLI)

Capitalización de mercado por Hancock Jaffe Laboratories (HJLI) es $4.55M

Hancock Jaffe Laboratories (HJLI) Acciones en Circulación

Hancock Jaffe Laboratories, Inc. is a medical device company in its developmental stage, specializing in creating advanced tissue-based and biologic solutions. These innovations are engineered to either sustain or significantly enhance the lives of patients afflicted with cardiovascular, peripheral arterial, and venous diseases, as well as end-stage renal disease (ESRD). The firm, headquartered in Irvine, California, maintains a dedicated team of nine full-time employees. Among its key initiatives, the company is actively developing implantable bioprosthetic devices for cardiovascular applications. This includes the Bioprosthetic Heart Valve (BHV), a swine-derived heart valve designed to mimic the function of a native heart valve and provide superior performance compared to current prosthetic options. Furthermore, the company is developing a Venous Valve, another bioprosthetic device sourced from pig tissue. This valve is specifically designed for individuals suffering from chronic venous insufficiency (CVI) in the lower limbs, a condition frequently resulting from damage to leg vein valves after the formation of deep venous blood clots.

Año	Acciones en circulación	Cambiar
Not enough data for the provided dates.

Año

Acciones en circulación

Cambiar

Not enough data for the provided dates.

Empresa	Acciones en circulación	Diferencia	País
Abbott Laboratories ABT.US	1.74B	-	US
Stryker Corporation SYK.US	383.50M	-	US
Medtronic plc MDT.US	1.28B	-	IE
Boston Scientific Corporation BSX.US	1.48B	-	US
Edwards Lifesciences Corporation EW.US	576.40M	-	US

Empresa

Acciones en circulación

Diferencia

País